Holger Lichau
About Holger Lichau
Holger Lichau is a Patent Examiner at the European Patent Office, where he has worked since 2007, specializing in polymers and multilayered materials. He previously held a position as a project leader at Fresenius Medical Care Deutschland GmbH and serves as a coach for new recruits.
Work at European Patent Office
Holger Lichau has been employed as a Patent Examiner at the European Patent Office (EPO) since 2007. He is based in The Hague, South Holland, Netherlands. In his role, he specializes in the examination of patents related to polymers, particularly multilayered and cellular materials. Lichau is also involved in opposition proceedings, which are critical in the patent process. Additionally, he serves as a coach for new recruits, helping to train and guide them in their roles at the EPO.
Previous Employment at Fresenius Medical Care
Before joining the European Patent Office, Holger Lichau worked at Fresenius Medical Care Deutschland GmbH from 2003 to 2007. In this position, he served as Projektleiter Membranen, where he was responsible for overseeing projects related to membranes. His tenure at Fresenius Medical Care took place in St. Wendel, Saarland, Germany, and lasted for four years.
Expertise in Patent Examination
Holger Lichau possesses extensive expertise in patent examination, particularly in the area of polymers. His focus on multilayered materials and cellular materials reflects his specialized knowledge in this field. Lichau has also held various classification roles, including classifier, quality nominee, and gérant, which demonstrate his comprehensive understanding of patent classification systems.
Coaching and Training Roles
In addition to his responsibilities as a Patent Examiner, Holger Lichau acts as a coach for new recruits at the European Patent Office. This role involves mentoring and providing guidance to newcomers, ensuring they are well-prepared for their duties. His experience in training reflects his commitment to fostering a knowledgeable workforce within the EPO.